ArticleFrontiers in oncology2021

Emerging a Novel VOPP1-EGFR Fusion Coexistent With T790M as an Acquired Resistance Mechanism to Prior Icotinib and Sensitive to Osimertinib in a Patient With EGFR L858R Lung Adenocarcinoma: A Case Report.

Xia Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.